158 related articles for article (PubMed ID: 33496103)
1. [Research progress in pharmacological effects of Erigeron breviscapus and its active ingredients for treatment of Alzheimer's disease].
Pu YZ; Su C
Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5650-5657. PubMed ID: 33496103
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and Pharmacological Mechanisms of Active Ingredients in
Fan H; Lin P; Kang Q; Zhao ZL; Wang J; Cheng JY
Curr Drug Metab; 2021; 22(1):24-39. PubMed ID: 33334284
[TBL] [Abstract][Full Text] [Related]
3. Estrogenic and neuroprotective properties of scutellarin from Erigeron breviscapus: a drug against postmenopausal symptoms and Alzheimer's disease.
Zhu JT; Choi RC; Li J; Xie HQ; Bi CW; Cheung AW; Dong TT; Jiang ZY; Chen JJ; Tsim KW
Planta Med; 2009 Nov; 75(14):1489-93. PubMed ID: 19533578
[TBL] [Abstract][Full Text] [Related]
4.
Dong X; Qu S
Front Pharmacol; 2022; 13():877872. PubMed ID: 35559239
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive review on the prevention and regulation of Alzheimer's disease by tea and its active ingredients.
Huang Y; Wei Y; Xu J; Wei X
Crit Rev Food Sci Nutr; 2023; 63(30):10560-10584. PubMed ID: 35647742
[TBL] [Abstract][Full Text] [Related]
6. A UPLC-ESI-MS/MS Method for Simultaneous Quantitation of Chlorogenic Acid, Scutellarin, and Scutellarein in Rat Plasma: Application to a Comparative Pharmacokinetic Study in Sham-Operated and MCAO Rats after Oral Administration of
Chen S; Li M; Li Y; Hu H; Li Y; Huang Y; Zheng L; Lu Y; Hu J; Lan Y; Wang A; Li Y; Gong Z; Wang Y
Molecules; 2018 Jul; 23(7):. PubMed ID: 30037063
[No Abstract] [Full Text] [Related]
7. Deep Sequencing Reveals the Effect of MeJA on Scutellarin Biosynthesis in Erigeron breviscapus.
Chen RB; Liu JH; Xiao Y; Zhang F; Chen JF; Ji Q; Tan HX; Huang X; Feng H; Huang BK; Chen WS; Zhang L
PLoS One; 2015; 10(12):e0143881. PubMed ID: 26656917
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Effects of Scutellarin, An Active Component of Genus Scutellaria and Erigeron: A Systematic Review.
Chledzik S; Strawa J; Matuszek K; Nazaruk J
Am J Chin Med; 2018; 46(2):319-337. PubMed ID: 29433387
[TBL] [Abstract][Full Text] [Related]
9. Advances in Anti-Diabetic Cognitive Dysfunction Effect of Erigeron Breviscapus (Vaniot) Hand-Mazz.
Gu S; Zhou Z; Zhang S; Cai Y
Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678547
[TBL] [Abstract][Full Text] [Related]
10. Systematic investigation of the Erigeron breviscapus mechanism for treating cerebrovascular disease.
Wang J; Zhang L; Liu B; Wang Q; Chen Y; Wang Z; Zhou J; Xiao W; Zheng C; Wang Y
J Ethnopharmacol; 2018 Oct; 224():429-440. PubMed ID: 29783016
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between expression of chalcone synthase gene (CHS) and scutellarin content in Erigeron breviscapus].
Liu T; Mu L; Liang YL; Wang JJ; Yang SC
Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(14):2241-4. PubMed ID: 24199547
[TBL] [Abstract][Full Text] [Related]
12. [Cloning and bioinformation analysis of flavone synthase II gene of Erigeron breviscapus].
Zhang GH; Li CT; Wang JJ; Zhang W; Chen JW; Yang JW; Yang SC
Zhongguo Zhong Yao Za Zhi; 2013 Jul; 38(14):2231-6. PubMed ID: 24199545
[TBL] [Abstract][Full Text] [Related]
13. Integrated Transcript and Metabolite Profiles Reveal That
Chen R; Chen X; Zhu T; Liu J; Xiang X; Yu J; Tan H; Gao S; Li Q; Fang Y; Chen W; Zhang L; Huang B
Front Plant Sci; 2018; 9():789. PubMed ID: 30013578
[TBL] [Abstract][Full Text] [Related]
14. Hybrid de novo genome assembly of the Chinese herbal fleabane Erigeron breviscapus.
Yang J; Zhang G; Zhang J; Liu H; Chen W; Wang X; Li Y; Dong Y; Yang S
Gigascience; 2017 Jun; 6(6):1-7. PubMed ID: 28431028
[TBL] [Abstract][Full Text] [Related]
15. Scutellarin Ameliorates Learning and Memory Deficit via Suppressing β-Amyloid Formation and Microglial Activation in Rats with Chronic Cerebral Hypoperfusion.
Shin JW; Kweon KJ; Kim DK; Kim P; Jeon TD; Maeng S; Sohn NW
Am J Chin Med; 2018; 46(6):1203-1223. PubMed ID: 30149759
[TBL] [Abstract][Full Text] [Related]
16. Development of a stable genetic transformation system in Erigeron breviscapus: a case study with EbYUC2 in relation to leaf number and flowering time.
Zhu Q; Lu YC; Xiong JL; Yang YH; Yang JL; Yang SC; Zhang GH; Sha BC; He SM
Planta; 2024 Mar; 259(5):98. PubMed ID: 38522041
[TBL] [Abstract][Full Text] [Related]
17. High quality genome of Erigeron breviscapus provides a reference for herbal plants in Asteraceae.
He S; Dong X; Zhang G; Fan W; Duan S; Shi H; Li D; Li R; Chen G; Long G; Zhao Y; Chen M; Yan M; Yang J; Lu Y; Zhou Y; Chen W; Dong Y; Yang S
Mol Ecol Resour; 2021 Jan; 21(1):153-169. PubMed ID: 32985109
[TBL] [Abstract][Full Text] [Related]
18. Advances in Chemical Constituents, Clinical Applications, Pharmacology, Pharmacokinetics and Toxicology of
Wu R; Liang Y; Xu M; Fu K; Zhang Y; Wu L; Wang Z
Front Pharmacol; 2021; 12():656335. PubMed ID: 34539390
[TBL] [Abstract][Full Text] [Related]
19. [Comparison on agronomy and quality characters and breeding of new strains of Erigeron breviscapus].
Yang S; Yang J; Pan Y; Li G; Liu B; Zhang Q; Wen G; Wang P
Zhongguo Zhong Yao Za Zhi; 2010 Mar; 35(5):554-7. PubMed ID: 20506809
[TBL] [Abstract][Full Text] [Related]
20. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
